Rothschild Investment LLC Castle Biosciences Inc Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 35 shares of CSTL stock, worth $1,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 15
133.33%
Holding current value
$1,165
Previous $327,000
205.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
177Shares Held
25.8MCall Options Held
511KPut Options Held
100-
Black Rock Inc. New York, NY3.04MShares$101 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$77.5 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$52.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$51.2 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$40.5 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $875M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...